Infinity Pharmaceuticals Inc (INFI) - Financial and Strategic SWOT Analysis Review

May 2021 | 54 pages | ID: I3226A39C28EN
GlobalData

Abstracts

Infinity Pharmaceuticals Inc (INFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Infinity Pharmaceuticals Inc (Infinity Pharmaceuticals) is a biopharmaceutical company which discovers and develops small molecule therapeutics for the treatment of cancer. The company’s pipeline candidate: IPI-549 selectively inhibits PI3K-gamma to reprogram tumor-associated macrophages and transforms immuno-oncology approach. It is evaluating IPI-549 as a monotherapy and in a combination therapy in various clinical trials for the treatment of various indications such advanced solid tumors, non-small cell lung cancer (NSCLC), melanoma, squamous cell carcinoma of the head and neck (SCCHN), triple negative breast cancer (TNBC), mesothelioma, and myeloid-derived suppressor cells (MDSC). The company has collaborations with other biopharmaceuticals companies for the development of its pipeline programs. Infinity Pharmaceuticals is headquartered in Cambridge, Massachusetts, the US.

Infinity Pharmaceuticals Inc Key Recent Developments

Mar 16,2021: Infinity Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Update on Eganelisib Development
Mar 10,2021: Infinity to Present at the Oppenheimer & Co. Annual Healthcare Conference
Mar 09,2021: Infinity Announces the Date of Its Fourth Quarter and Full Year 2020 Financial Results Conference Call and Webcast
Feb 18,2021: Infinity Announces Closing of $92 Million Public Offering of Common Stock
Feb 11,2021: Infinity Pharmaceuticals to Present at Upcoming BIO CEO & Investor Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Infinity Pharmaceuticals Inc - Key Facts
Infinity Pharmaceuticals Inc - Key Employees
Infinity Pharmaceuticals Inc - Key Employee Biographies
Infinity Pharmaceuticals Inc - Major Products and Services
Infinity Pharmaceuticals Inc - History
Infinity Pharmaceuticals Inc - Company Statement
Infinity Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Infinity Pharmaceuticals Inc - Business Description
Business Segment: Collaboration Revenue
Performance
Business Segment: Royalty Revenue
Performance
R&D Overview
Infinity Pharmaceuticals Inc - Corporate Strategy
Infinity Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Infinity Pharmaceuticals Inc - Strengths
Infinity Pharmaceuticals Inc - Weaknesses
Infinity Pharmaceuticals Inc - Opportunities
Infinity Pharmaceuticals Inc - Threats
Infinity Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Infinity Pharmaceuticals Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 16, 2021: Infinity Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Update on Eganelisib Development
Mar 10, 2021: Infinity to Present at the Oppenheimer & Co. Annual Healthcare Conference
Mar 09, 2021: Infinity Announces the Date of Its Fourth Quarter and Full Year 2020 Financial Results Conference Call and Webcast
Feb 11, 2021: Infinity Pharmaceuticals to Present at Upcoming BIO CEO & Investor Conference
Nov 09, 2020: Infinity Pharmaceuticals provides company update and third quarter 2020 financial results
Jul 30, 2020: Infinity Pharmaceuticals provides company update and second quarter 2020 financial results
May 11, 2020: Infinity Pharmaceuticals provides company update and first quarter 2020 financial results
Mar 17, 2020: Infinity Pharmaceuticals augments Board of Directors with appointment of Richard Gaynor, M.D.
Mar 03, 2020: Infinity Pharmaceuticals reports full year 2019 financial results and provides company update
Jan 13, 2020: Infinity Pharmaceuticals provides 2020 goals and financial guidance

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Infinity Pharmaceuticals Inc, Key Facts
Infinity Pharmaceuticals Inc, Key Employees
Infinity Pharmaceuticals Inc, Key Employee Biographies
Infinity Pharmaceuticals Inc, Major Products and Services
Infinity Pharmaceuticals Inc, History
Infinity Pharmaceuticals Inc, Subsidiaries
Infinity Pharmaceuticals Inc, Key Competitors
Infinity Pharmaceuticals Inc, Ratios based on current share price
Infinity Pharmaceuticals Inc, Annual Ratios
Infinity Pharmaceuticals Inc, Annual Ratios (Cont...1)
Infinity Pharmaceuticals Inc, Interim Ratios
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Infinity Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Infinity Pharmaceuticals Inc, Performance Chart (2016 - 2020)
Infinity Pharmaceuticals Inc, Ratio Charts
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Infinity Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021